Darmstadt-based BIOVOX, an organization pioneering sustainable bioplastics for medical purposes, introduced the profitable closing of its €2.2 million seed spherical. The spherical was led by Excessive-Tech Gründerfonds (HTGF) with important participation from Beteiligungs-Managementgesellschaft Hessen mbH (BMH) and a gaggle of present and new traders together with Auxxo, Otto Braun, Petra Wörwag and Katharina Klohe as properly members of the enterprise angel membership higher ventures and Enterprise Angels FrankfurtRheinMain. The funding will allow BIOVOX to speed up the event and manufacturing of its portfolio of progressive bioplastic options designed to revolutionise the healthcare trade.
The healthcare sector is – with 4.4% – a significant contributor to world greenhouse gasoline emissions, with plastics in healthcare alone chargeable for carbon emissions akin to the full emissions of a Sweden or Denmark. Sterile single use medical merchandise are important for sustaining excessive hygiene requirements and availability at an inexpensive value level, but healthcare can not proceed with the linear economic system based mostly on fossil sources, overstepping the boundaries of a wholesome planet and due to this fact resulting in extra well being issues in the long term.
BIOVOX is addressing this essential situation of a high-carbon linear economic system in healthcare by having developed the world’s first sustainable medical-grade bioplastics for gadgets and packaging. The corporate produces and provides biocompatible and sustainable plastics that meet the very best regulatory requirements of in the present day and tomorrow.
These progressive supplies are bio-based, examined for biocompatibility, had been developed and manufactured below BIOVOX’ ISO 13485-certified medical high quality administration system, and scale back the lifecycle carbon footprint by 50 to 85% in comparison with typical virgin fossil plastics. BIOVOX’s line of bioplastics is designed for a variety of medical, pharmaceutical and laboratory purposes, together with consumables, disposables, packaging, surgical devices, and endoscopy gadgets. The supplies meet probably the most stringent regulatory requirements, making certain top quality and affected person security.
The newly secured funding allows BIOVOX headed by founders and mechanical engineers CEO Julian Lotz, CTO Vinzenz Nienhaus and COO Carmen Rommel to scale operations by establishing a proprietary technical centre and to broaden the gross sales and buyer success staff.
“With the assist of our new and present traders, we are going to scale the organisation to cater to all the purchasers presently ready for our sustainable supplies. Our pioneering merchandise have already created a powerful model and a wealthy pipeline. Now we now have the monetary means to assist our prospects even higher in growing a extra setting pleasant product vary prepared for the round economic system. Let’s create full traction for sustainable healthcare plastics,” mentioned Dr.-Ing. Julian Lotz, CEO of BIOVOX GmbH.
Based in 2021, BIOVOX is on the forefront of the sustainable healthcare market, setting the usual for bioplastic compounds constituted of renewable sources. Greater than 50 prospects, together with many section leaders in medical gadgets, are working with BIOVOX to develop inexperienced healthcare options. One buyer has already launched its first product utilizing BIOVOX supplies.
Tilmann Petersen, Funding Supervisor at HTGF, added: “With BIOVOX, we’re funding a staff of visionaries whose technological brilliance and deep understanding of regulatory affairs are revolutionising the event of sustainable plastics for the life sciences trade. Not solely do they communicate the purchasers’ language, however they’ve validated their options by quite a few profitable pilot initiatives and have already introduced a product to market. Their contribution to lowering the carbon footprint in healthcare will likely be immense and we at HTGF are proud to assist such a know-how for a greater setting and make it commercially profitable.”
